ABSTRACT
The outbreak of the COVID-19 pandemic, since time surged across nations, has affected millions of people in several nations. With over 268 million cases and 5.28 million reported deaths, the caseload is rising further in many countries. The stipulated measures are undertaken worldwide to contain the spread of infections through social distancing, quarantine, and lockdown in the regions. The numerous lockdowns imposed across nations in the past several months to contain terrorism have slowed economic growth. Isolation, grief, and loss of income trigger mental health conditions or aggravate existing ones. In the long term, the impacts on the population are wide-ranging from depression, posttraumatic stress syndrome, anxiety, insomnia, domestic and substance abuse, emotional chaos, and behavioral changes. People with preexisting morbidities face higher chances of acute severe medical outcomes that may eventually be fatal. These factors affect an individual's mental health, leading to economic and social withdrawal. The first global data drawn from the survey of the 130 severely affected countries suggests that symptoms of anxiety, depression, and severe psychological reactions amount to 15 to 30%. Addressing such a population's mental health conditions has become a pressing issue for healthcare providers. The challenges involve the identification of the population segment requiring medical services to treat psychological and mental illnesses post-COVID-19 pandemic. At the same time, addressing the privacy concerns of such a large population is also pivotal. The privacy regulatory frameworks adopted by the regional and federal governments are pressing upon procedures to preserve the privacy of people suffering from post-COVID-19 psychological distress syndrome. In this chapter, the privacy mechanisms are detailed, which will provide non-disclosure of personal and sensitive data during treatments. The exchange of health-related data and personal identifiers is subject to territorial privacy rules without revealing personally identifiable information (PII). © 2022 Nova Science Publishers, Inc. All rights reserved.